Sample information curated by ChIP-Atlas

Antigen

Antigen Class
TFs and others
Antigen
BDP1

Cell type

Cell type Class
Blood
Cell type
K-562
Primary Tissue
Blood
Tissue Diagnosis
Leukemia Chronic Myelogenous

Attributes by original data submitter

Sample

source_name
K562
biomaterial_provider
ATCC
lab
Harvard
lab description
Struhl - Harvard University
datatype
ChipSeq
datatype description
Chromatin IP Sequencing
cell
K562
cell organism
human
cell description
leukemia, "The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises." - ATCC
cell karyotype
cancer
cell lineage
mesoderm
cell sex
F
treatment
None
treatment description
No special treatment or protocol applies
antibody
BDP1
antibody antibodydescription
Rabbit polyclonal - Antiserum 2663 was raised by immunizing rabbits with synthetic peptide CSDRYRIYKAQKLRE (human Bdp1 residues 139?153) coupled to KLH. Antibody Target: BDP1
antibody targetdescription
'B double-prime 1', subunit of RNA polymerase III transcription initiation factor IIIB
antibody vendorname
Donated by Dr. RJ White, The Beatson Institute for Cancer Research
antibody vendorid
2663
control
std
control description
Standard input signal for most experiments.
control
std
control description
Standard input signal for most experiments.
controlid
wgEncodeEH000615
labversion
fragmented with both a probe sonicator and a Misonix sonicator, and precipitated with protein A sepharose beads
replicate
1

Sequenced DNA Library

library_name
GSM935594: Harvard_ChipSeq_K562_BDP1_std
library_strategy
ChIP-Seq
library_source
GENOMIC
library_selection
ChIP

Sequencing Platform

instrument_model
Illumina Genome Analyzer

hg19

Number of total reads
58146027
Reads aligned (%)
53.7
Duplicates removed (%)
8.7
Number of peaks
1365 (qval < 1E-05)

hg38

Number of total reads
58146027
Reads aligned (%)
54.8
Duplicates removed (%)
7.6
Number of peaks
927 (qval < 1E-05)

Base call quality data from DBCLS SRA